Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 76956 · Class II · Central Jersey Blood Center, Inc.
Key facts
| Event ID | 76956 |
|---|---|
| Recall numbers | B-0520-2017 |
| Recalling firm | Central Jersey Blood Center, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Apheresis product, with unacceptably high platelet concentrations, was distributed. |
| Initiation date | Mar 13, 2017 |
| Report date | May 3, 2017 |
| Termination date | Apr 27, 2017 |
| City | Eatontown |
| State | NJ |
| Country | United States |
| FEI number | 3008300945 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: